Phase I study of oral doxifluridine using two schedules

Eur J Cancer Clin Oncol. 1989 May;25(5):905-8. doi: 10.1016/0277-5379(89)90139-9.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / toxicity
  • Drug Administration Schedule
  • Drug Evaluation
  • Drug Tolerance
  • Female
  • Floxuridine / administration & dosage*
  • Floxuridine / toxicity
  • Humans
  • Isomerism
  • Male
  • Middle Aged
  • Neoplasms / drug therapy

Substances

  • Antineoplastic Agents
  • Floxuridine
  • doxifluridine